On the second day of bidding, both Vikran Engineering IPO and Anlon Healthcare IPO comfortably sailed through, with Vikran Engineering IPO being subscribed 3.75 times and Anlon Healthcare IPO receiving a subscription status of 2.42 times by 11:40 IST, according to BSE data.
According to Harshal Dasani Business Head, INVasset PMS, the ₹121-crore Anlon Healthcare IPO, which will closw on August 29, was driven largely by strong retail demand, while institutional and NII segments were softer. The grey market premium hovered around 5–6%, indicating a muted listing gain over its upper price band. Proceeds are earmarked for expanding manufacturing capacity, funding working capital, reducing debt, and meeting general corporate requirements. While the response was moderate, the company’s focus on scaling capacity and balancing its debt profile has drawn attention from selective investors seeking stability over aggressive growth.
By contrast, the much larger ₹772-crore Vikran Engineering IPO witnessed robust appetite, getting fully booked within the first two hours of opening and closing with subscription around two times overall. Grey market signals were stronger here, with premiums near 17–18%, suggesting a healthier listing gain potential. Investors have been encouraged by the company’s sizeable order book and infrastructure tailwinds, though concerns linger around working capital intensity and regulatory overhangs.
Still, in a volatile market backdrop, Vikran Engineering has managed to generate a stronger pre-listing buzz than Anlon, making it the more closely watched debut in this round of offerings, believes Dasani.
Let’s take a look at the grey market premium trends
Vikran Engineering IPO GMP today, or grey market premium, is +10. According to investorgain.com, Vikran Engineering’s share price traded at a premium of ₹10 in the grey market on Thursday.
Considering the upper end of the IPO price band and the current premium in the grey market, the estimated listing price of Vikran Engineering shares was ₹107 apiece, which is 10.31% higher than the IPO price of ₹97.
Based on the grey market activities from the last 11 sessions, the present GMP ( ₹10) indicates a trend towards the lower end. As noted by experts, the minimum GMP recorded is ₹0.00, while the maximum GMP stands at ₹21.
Anlon Healthcare IPO GMP today is +5. This indicates Anlon Healthcare share price was trading at a premium of ₹5 in the grey market, according to investorgain.com.
Considering the upper end of the IPO price band and the current premium in the grey market, the estimated listing price of Anlon Healthcare shares is ₹96 apiece, which is 5.49% higher than the IPO price of ₹91.
Due to the grey market activities observed over the past eight sessions, today’s IPO GMP is on the rise, suggesting a robust listing ahead. According to analysts, the lowest GMP recorded is ₹0.00, and the highest GMP noted is ₹5.
‘Grey market premium’ indicates investors’ readiness to pay more than the issue price.
Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
About The Author
